Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Literature
1.
Velavan TP, Meyer CG (2020) The COVID-19 epidemic. Tropical Med Int Health 25(3):278–280CrossRef
2.
South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Phys Heart Circ Phys 318(5):H1084–H1090
3.
Prasa D, Hoffmann-Walbeck P, Barth S, Stedtler U, Ceschi A, Färber E, Genser D, Seidel C, Deters M (2013) Angiotensin II antagonists–an assessment of their acute toxicity. Clin Toxicol 51(5):429–434CrossRef
4.
Sommerstein R, Gräni C (2020) Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ 368:m810
5.
6.
Phadke M, Saunik S (2020) Rapid response: use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan corona virus infections—novel mode of treatment. BMJ 368:m406
7.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565–574CrossRef
8.
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382(17):1653–1659CrossRef
9.
Chappell MC (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Phys Heart Circ Phys 310(2):H137–H152
10.
Ciavarella C, Motta I, Valente S, Pasquinelli G (2020) Pharmacological (or synthetic) and nutritional agonists of PPAR-γ as candidates for cytokine storm modulation in COVID-19 disease. Molecules 25(9):2076CrossRef
11.
Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med S2213-2600(2220):30116–30118
12.
Metadata
Title
Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view
Authors
Farshad M. Shirazi
Shireen Banerji
Samaneh Nakhaee
Omid Mehrpour
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03932-6

Other articles of this Issue 10/2020

European Journal of Clinical Microbiology & Infectious Diseases 10/2020 Go to the issue

Original Article

Analysis of C. difficile infection–related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

Correction

Correction to: Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures

Original Article

Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens

Original Article

Relationships among streptococci from the mitis group, misidentified as Streptococcus pneumoniae

Brief Report

First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Original Article

Recent clinical relevance of mono-genital colonization/infection by Ureaplasma parvum
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits